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Abstract
Introduction: This study assessed the feasibility of a nurse-delivered 
cognitive behavioural therapy (CBT) for the treatment of irritable bowel 
syndrome (IBS).
Methods and analysis: A mixed-method design was used. Twenty 
participants were randomly allocated to high-intensity CBT (n=5), guided 
self-help (n=5), self-help only (n=5) or treatment as usual (n=5). Ten 
intervention participants completed semi-structured interviews. Quantitative 
data were analysed using descriptive statistics; qualitative data were 
analysed using group thematic analysis.
Results: Barriers to the interventions used were negative preconceptions 
about treatment, factors relating to supporting materials and stigma. 
Treatment facilitators included therapist-facilitated relaxation, narratives 
located within self-help materials and social support mechanisms.
Conclusion: Further development of the low-intensity interventions in 
collaboration with service users is required to improve intervention 
acceptability and relevance.
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Introduction
Irritable Bowel Syndrome (IBS) is a functional gastrointestinal disorder 
characterised by symptoms such as altered bowel habit, bloating and 
abdominal pain (Lacy et al., 2016). People with IBS may be troubled by 
concerns relating to the cause and the effects of their condition (North et al., 
2007), report a poor quality of life and often experience work-related 
absenteeism (Halder et al., 2004). Moreover, IBS places a significant strain 
on healthcare resources (Canavan et al., 2014 , Longstreth et al., 2003). 
Psychosocial factors and stress are associated with the onset of the disorder 
and related to the severity and prognosis of IBS symptoms (Gwee et al., 
1996). 
CBT is particularly useful for addressing negative thought patterns(North et 
al., 2007), catastrophizing cognitions and avoidant behaviours (Hunt et al., 
2009), and is well supported empirically for IBS (Craske et al., 2011 , 
Drossman et al., 2003 , Kennedy et al., 2005). A systematic review identified 
issues regarding the methodological quality and power of related studies 
(Zijdenbos et al., 2009). The provision of CBT interventions for patients with 
functional gastrointestinal disorders is lacking in many health care systems 
and, in the context of our own practice, NHS patients within the UK have no 
routine access to CBT interventions for the treatment of IBS. The National 
Institute for Health and Clinical Excellence (NICE), currently recommend 
referral for psychological therapy for people with IBS who fail to respond to 
the medical management of IBS (NICE, 2017).
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Few studies have evaluated psychological interventions which address 
concerns regarding treatment provision and intervention accessibility 
(Lackner et al., 2008). This randomised controlled trial reports on aspects of 
the feasibility and acceptability of a nurse-delivered, low-intensity (LI) CBT, 
guided self-help intervention for the treatment of IBS compared to high-
intensity (HI) CBT treatment, self-help (SH) without therapist support and a 
treatment as usual control condition. For IBS patients attending secondary 
care gastrointestinal clinics, it was envisaged that such an LI-CBT 
intervention might provide many of the benefits, but be more accessible to 
participants and more feasible to implement compared to HI-CBT 
interventions.
Methods 
Study aim
To investigate the feasibility and acceptability of LI-CBT interventions for 
participants with IBS within secondary care gastrointestinal clinics
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Study objectives
To develop a tailored nurse-delivered LI-CBT treatment protocol
To examine the number of participants needed to screen in relation to the 
numbers successfully randomised into the study
To gather reasons why participants may not take part in the trialled 
interventions
To explore the experience of participants undergoing treatment conditions
To identify barriers and facilitators to the implementation of the trial 
interventions
Study design
An embedded mixed method design comprising a feasibility randomised 
controlled trial (RCT) and a nested qualitative component was used (Johnson 
and Onwuegbuzie, 2004). A criticism of RCTs is the methods potential 
inability to consider the context of interventions (Tarquinio et al., 2015). It 
was hypothesised that the collection of qualitative data during the trial would
also help identify barriers to the implementation of CBT interventions 
consistent with the Medical Research Council’s guidelines for the evaluation 
of complex interventions (MRC, 2008). Mixed methods research provides 
robust and rigorous approaches to research (Anaf and Sheppard, 2007) and 
creates a richer understanding of phenomena (Creswell and Plano Clark, 
2007). A mixed methods research (MMR) approach, underpinned by a 
pragmatic philosophy, was therefore used to draw from the strengths of both
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qualitative and quantitative approaches (Johnson and Onwuegbuzie, 2004). 
The incorporation of qualitative methods within the RCT ensured that the 
research was able to consider social experiences and meaning (Denzin and 
Lincoln, 2000).
Participants
Adults (over 18 years of age) fulfilling Rome III criteria for IBS were included 
(The Rome Foundation, 2017).
Inclusion criteria
 Documented medical diagnosis of IBS
 Participants with IBS who met Rome III Criteria
 Able to read, write and speak English
 Able to provide written informed consent
Exclusion criteria
 Already receiving psychological therapy or hypnotherapy
 Existing diagnosis of bowel disease based on endoscopic or histologic 
criteria (i.e. Crohn’s Disease, Ulcerative Colitis, coeliac disease)
 Presence or history of structural or surgical diseases of the GI tract (not
including appendix or gall bladder surgery)
 Evidence of alcohol or substance misuse
 An established cause for bowel symptoms other than IBS (i.e. 
medication use)
5
 The presence of suicidal ideation or self-harm
 Significant psychiatric co-morbidity (such as schizophrenia or bipolar 
disorder)
 Currently taking part in other research studies
Intervention
The researchers adapted the protocol and SH materials originally developed 
by Hunt and colleagues (Hunt et al., 2009) at the University of Pennsylvania 
USA so that treatment could be delivered within a face-to-face, LI format. 
The intervention comprised of an initial sixty-minute assessment session, 
with five further thirty-minute treatment sessions over a six-week treatment 
period working through the following modules with the nurse therapist.
 An introduction to IBS
 Relaxation training
 The cognitive model of stress management
 The cognitive model of IBS and behavioural experiments
 Managing avoidance using exposure
 Diet and IBS
Comparators
The nursing intervention was compared to: a) a HI-CBT intervention over 
eleven treatment sessions, delivered by an HI therapist, b) a six module CBT 
6
based SH workbook as a stand-alone intervention without therapist support 
and c) a treatment as usual (TAU) control condition consisting of routine 
medical care based upon best practice guidelines. 
Within the HI intervention, the psychotherapist delivered treatment to 
participants based upon a treatment protocol developed from the work of 
Toner (Toner et al., 2000). Treatment consisted of eleven treatment sessions 
at weekly intervals. The first of these sessions was two hours in duration 
allowing for comprehensive assessment, with subsequent sessions lasting up
to one hour. Within the SH intervention, participants were issued the same 
six module SH treatment workbooks as utilised within the LI nursing 
intervention. In order to identify if additional benefits arising could be 
attributed to the involvement of the nurse within LI-CBT, the SH workbooks 
were used as a stand-alone intervention in order to facilitate direct 
comparison between the two groups. There was therefore no involvement of 
the nurse therapist during participant’s exposure to the SH intervention.
Intervention fidelity
The interventions delivered within this study were audio recorded and 10% 
were monitored for compliance to study protocol. Therapists also completed 
a report form confirming interventions were delivered as intended. No 
breaches of study protocol were reported on case report forms returned by 
therapists during the conduct of the study. The monitoring data for the LI-
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CBT sessions confirms that treatment was delivered as intended, although 
within HI-CBT treatment, some inconsistencies with the follow up of 
homework activities was noted. There were no major deviations from 
protocol.
Outcomes
The following quantitative measures were completed by participants by mail 
at 12 weeks and 26 weeks’ post randomisation. 
IBS Symptom Severity
GSRS-IBS consists of 13 items with five symptom sub-domains including: 
abdominal pain, bloating, diarrhoea, constipation and satiety. Participants 
were asked to record the previous 7 days’ symptoms indicating responses on
a 7-point Likert scale. Mean item scores (between 1 and 7) are calculated for 
each of the five sub domains. Two-hundred-and-thirty-four participants were 
involved in Wiklund and colleagues psychometric evaluation of GSRS-IBS 
(Wiklund et al., 2003). The internal consistency reliability was high, ranging 
from 0.74 (pain) to 0.85 (satiety). The associations between similar 
constructs in the GSRS-IBS and the various HRQL scores supported the GSRS-
IBS construct validity. 
Quality of Life
IBS-QOL consists of 34 self-report Likert scales specific to IBS. IBS-QOL also 
makes possible the analysis of eight sub domains which include: dysphoria, 
interference with activity, body image, health worry, food avoidance, social 
reaction, sexual factors and relationships. IBS-QOL has undergone two 
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rigorous evaluations, the first demonstrating high reproducibility and internal
consistency (Patrick et al., 1998), the second longitudinal construct validity 
(Drossman et al., 2000). 
Anxiety and Depression
Levels of depression were measured with PHQ-9 (Kroenke et al., 2001), and 
anxiety using GAD-7 (Löwe et al., 2008). Both measures consist of 9 and 7 
item self-report Likert scales respectively indicating depression and anxiety 
severity scores. PHQ-9 has a sensitivity of 88% and a specificity of 88% for 
major depression (Kroenke et al., 2001). PHQ-9 scores of 5, 10, 15, and 20 
represent mild, moderate, moderately severe, and severe depression, 
respectively. PHQ-9 has been validated for the screening of depression in 
community (Nease and Maloin, 2003), secondary outpatient (van 
Steenbergen-Weijenburg et al., 2010) and prenatal care settings (Sidebottom
et al., 2012). With receiver operating curves of n = 127; 0.930, the PHQ-9 is 
a valid tool for establishing levels of depression among adults from a variety 
of medical populations (Rathore et al., 2014). GAD-7 is validated for 
measuring levels of general anxiety disorder among general populations 
(Löwe et al., 2008). With a threshold score of 10, GAD-7 has a sensitivity of 
89% and specificity of 82% for generalized anxiety disorder(Williams, 2014). 
Like PHQ-9, GAD-7 has been validated in recent studies when utilised for 
screening within primary care (Mohd Sidik et al., 2012), perinatal care 
(Zhong et al., 2015) and applied to complex medical problems such as MS 
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(Terrill et al., 2015). The GAD-7 produces a score between 0-21.  Scores of 5, 
10 and 15 represent mild, moderate and severe anxiety respectively (Spitzer 
et al., 2006). 
Recruitment and sample selection
Potentially eligible clinic patients were identified by a member of their care 
team and were given participant information packs. Patients expressed 
interest in becoming study participants by the return of a reply slip. Posters 
were also deployed on clinic and hospital notice boards. Authors suggest that
12 participants per group should be sufficient for calculating the mean and 
variance which can be used to determine full scale trial sample sizes (Julious,
2005), although there is no consensus on the sample size which should be 
recruited to feasibility studies. A pragmatic decision was therefore made to 
randomise 60 participants across four treatment conditions. Participants from
the three intervention conditions were invited to participate in post-
intervention interviews. As recommended within the consolidated standards 
for the reporting of trials (CONSORT, 2012), figure 1 demonstrates the flow of
participants throughout the study period.
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Randomisation and blinding
The principle investigator (AD) screened all participants and randomised 
eligible participants using an online randomisation system (see 
www.sealedenvelope.com). Participants were randomised across the four 
treatment conditions using random permuted blocks. All quantitative, post 
intervention outcome data were successfully collected by a research 
assistant blind to participant allocation.
Patient and public involvement
A patient advisory group (PAG) was involved in the design of the study and 
review of study documents from the outset. The PAG highlighted potential 
barriers to the recruitment and selection of participants and helped shape 
the materials used within the nurse-delivered and SH interventions through 
peer review processes.
Ethical issues
Participants were made aware of the potential identification of clinical 
anxiety and/or clinical depression during recruitment and selection. The 
participants’ hospital care team and general practitioner were notified where 
a moderate to severe level of anxiety or depression was detected. The study 
was granted a favourable ethical opinion by the Nottingham 2 Local Research
Ethics Committee (REC ref: 13/EM/0428). Host organisation approval was 
sought from the host NHS Trust. All participants taking part in this study 
provided written informed consent. All participants identified as ineligible for 
randomisation during the screening process completed a baseline data set 
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and this marked the end of their participation. All randomised participants 
could continue taking part until the completion of the 26 week follow up.
Results
Analysis of quantitative data
Quantitative data were entered into SPSS version 22 for analysis. Only 
descriptive statistics were generated to describe the range of data collected. 
No attempts were made to produce inferential data which was beyond the 
remit of feasibility.
Qualitative data thematic analysis
Ten participants took part in the post-intervention interviews; three from the 
HI treatment regimen, three from LI and four from the SH intervention. The 
average interview duration for each of the interview groups was 47 minutes 
for the HI treatment participants, 41 minutes for LI participants and 30 
minutes for those from the SH intervention.
Knowledge claims which arise from the conduct of qualitative research 
should be powerful and convincing (Kvale, 1996). The qualitative methods 
were therefore designed to be justifiable and sufficient to demonstrate 
substantial rigor and quality (Ballinger, 2006). The consolidated criteria for 
reporting qualitative research (CORE-Q), is a 32-item checklist for ensuring 
quality and rigor when reporting empirical research using interviews and 
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focus groups (Tong et al., 2007). The proposed qualitative methods were 
therefore consistent with the standards listed within the CORE-Q checklist. 
The qualitative element of the study aimed to capture knowledge which was 
located in the minds and personal experiences of others (Nespor and 
Barylske, 1991). Interview methods permitted the exploration of these 
experiences and the subsequent textual portrayal of the phenomena 
(Patterson and Williams, 2002). Interview questions were used by the 
interviewer to seek clarification, illustration and further exploration regarding
important issues (Parahoo, 2006). The interview questions were structured 
around the need to identify barriers to the use of psychotherapy amongst 
patients with IBS and to explore experiences that participants might have 
when receiving the trial interventions. The interview schedule consisted of 
open ended questions which allowed participants to freely express their 
feelings and experiences.
Interviews were conducted as per ethical approval by a co-investigator (EH) 
who was not connected to the delivery of interventions. Interviews took place
within facilities located within a digestive diseases research centre. The 
interviewer had a background in the delivery of LI psychological 
interventions for common mental health problems. Interview recordings were
transcribed verbatim by AD and analysed as per the thematic framework 
analysis described by Ritchie and Spencer (Ritchie and Spencer, 1994). In 
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order to improve the rigour during the analysis and guard against 
investigator bias, a group analysis approach was used to analyse the 
interview data (Gunaratnam, 2009). Both the investigator (AD) and the 
interviewer (EH) analysed the interview transcripts under the supervision of 
an experienced qualitative researcher. The data were analysed and themes 
identified within the data as follows.
1. The researchers became immersed in the data by exploring the 
richness, depth and diversity. AD transcribed audio data for analysis 
which were verified by the interviewer (EH).
2. The analysts independently produced a draft thematic framework. This 
involved the identification and assembly of key issues, concepts and 
themes which could be used to reference the range of data. The two 
analysts then jointly agreed upon the thematic framework.
3. The thematic framework was applied to the interview transcripts and 
charts were built to build a picture of the data.
4. The analysts jointly compared the perceptions, accounts, and 
experiences within the data and identified the key themes.
The four main themes identified during framework analysis consisted of; the 
participant’s initial perceptions of treatment, the experience of executing 
therapeutic tasks, practical considerations for engagement and the 
participants perceived utility of treatment. Further themes were identified 
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which did not relate directly to the objectives of the study, these will be 
reported elsewhere.
Recruitment, retention and participant characteristics
One hundred and four patients were approached with details regarding the 
study. Overall, 33 expressions of interest were received, which equates to a 
response rate of 34.4%. Ethical approval was therefore sought to ask 
participants who chose not to take part in the study their reasons for not 
doing so. The following table (table 1) lists the responses from a small 
sample (n=10) of participants who were contacted to discover the factors 
affecting their decision not to participate. As per ethical approval, 
participants were under no obligation to provide this information and 
identifiable data were not collected.
Table 1: Reasons for participants not wishing to express further interest in research upon
invitation to the study
Patient Reasons offered for not expressing further interest
1 Level of commitment too great
2 Generally of no interest
3 Does not have the time/symptoms resolved
4 Personal circumstances (immediate family unwell)
5 Too busy to take part
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6 Does not want to make stress levels worse
7 Well controlled on new medicines
8 Too busy to take part
9 Receiving therapy via community services
10 Too busy to take part
Of the 33 participants who responded to the invitations, 22 attended 
screening for enrolment to the study. Table 2 shows the reasons why some 
patients who originally expressed an interest in participating in the study 
decided not to take part.
Table 3 presents the characteristics of the twenty participants who were 
screened and found to be eligible to participate in the study in accordance 
with the inclusion and exclusion criteria. 
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Table 2: Reasons for participants who expressed further interest in research not taking part in the
study
Patient Reasons for not taking part
1 Does not want to take part due to holidays
2 Moved abroad
3 Proximity issues and difficulty travelling to trial centre
4 Too busy to take part
5 Unable to make contact with respondent
6 Unable to make contact with respondent
7 Too busy to take part
8 Too busy to take part due to university work
9 Did not attend screening due to personal problems
10 Unable to make contact with respondent
11 Unable to read or write in English (excluded)
  Table 3: Participant demographic data
 
Treatment condition
HI-CBT LI-CBT SH TAU Total
(n = 5) (n = 5) (n = 5) (n = 5) (n = 20)
  Female, n (%) 5 (100) 4 (80) 4 (80) 4 (80) 17 (85)
  Age (years), Mean (S.D.) 56.6 
(14.4)
40.0 
(18.9)
37.2 
(18.5)
44.0 
(15.7)
44.5 
(17.4)
  Age diagnosed with IBS (years), Mean (S.D.) 47.8 
(10.9)
37.4 
(18.6)
31.4 
(12.1)
32.8 
(13.6)
37.4 
(14.5)
  Rome criteria, n (%) IBS-C 0 (0) 1 (20) 1 (20) 0 (0) 2 (10)
IBS-D 3 (60) 2 (40) 2 (40) 2 (40) 9 (45)
IBS-M 2 (40) 2 (40) 2 (40) 3 (60) 9 (45)
  IBS onset associated with infective episode, n (%) 0 (0) 3 (60) 0 (0) 0 (0) 3 (15)
  Previous received psychotherapy, n (%) 1 (20) 0 (0) 1 (20) 0 (0) 2 (10)
  Antidepressant use, n (%) 2 (40) 0 (0) 2 (40) 2 (40) 6 (30)
  Ethnic origin, n (%) White British 4 (80) 5 (100) 5 (100) 5 (100) 19 (95)
White other 1 (20) 0 (0) 0 (0) 0 (0) 1 (5)
  Household income, n (%) < £15000 0 (0) 1 (20) 1 (20) 0 (0) 2 (10)
£15000-£19999 0 (0) 2 (40) 0 (0) 0 (0) 2 (10)
£20000-£29999 2 (40) 1 (20) 1 (20) 2 (40) 6 (30)
£30000-£39999 2 (40) 0 (0) 1 (20) 0 (0) 3 (15)
£40000-£49999 0 (0) 0 (0) 1 (20) 1 (20) 2 (10)
£60000-£69999 0 (0) 1 (20) 1 (20) 2 (40) 4 (20)
£70000-£99999 1 (20) 0 (0) 0 (0) 0 (0) 1 (5)
  Marital status, n (%) Divorced or separated 1 (20) 0 (0) 0 (0) 1 (20) 2 (10)
Living as married 1 (20) 0 (0) 0 (0) 0 (0) 1 (5)
Married 3 (60) 1 (20) 1 (20) 3 (60) 8 (40)
Single 0 (0) 3 (60) 4 (80) 1 (20) 8 (40)
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Widowed 0 (0) 1 (20) 0 (0) 0 (0) 1 (5)
  Education, n (%) Grammar sch/college 1 (20) 2 (40) 3 (60)   2 (40) 8 (40)
Primary school 0 (0) 0 (0) 1 (20) 0 (0) 1 (5)
Secondary school 2 (40) 0 (0) 0 (0) 2 (40) 4 (20)
Technical/professional 1 (20) 1 (20) 0 (0) 0 (0) 2 (10)
University degree 1 (20) 2 (40) 1 (20) 1 (20) 5 (25)
  Smoking status, n (%) Currently smoking 0 (0) 0 (0) 2 (40) 1 (20) 3 (15)
Never smoked 5 (100) 4 (80) 3 (60) 2 (40) 14 (70)
Previously smoked 0 (0) 1 (20) 0 (0) 2 (40) 3 (15)
  Alcohol consumption U/week, mean (S.D.) 2.0 (2.9) 9.3 (13.6)
0
(0)
5.7 
(6.1) 4.3 (7.9)
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Eighty five percent of the participants randomised to the feasibility study 
were female; there were no males in the HI-CBT treatment condition. The 
mean age of participants was 44.5 years (S.D. = 17.4) which was similar 
within the LI-CBT, SH and TAU conditions. Participants in the HI-CBT 
intervention were slightly older with a mean age in years of 56.6 (S.D. = 
14.4). The sample represents an equal mix of participants with IBS-D and 
IBS-M type IBS, and 10% were found to have IBS-C consistent with Rome III 
criteria. No participants were found to have IBS-U. The average age of 
participants diagnosed with IBS was 37.4 years (S.D. = 14.5), which was 
similar within the LI-CBT, SH and TAU conditions. Participants in the HI-CBT 
intervention were slightly older when diagnosed with IBS, with a mean age in
years of 47.8 (S.D. = 10.9). Thirty percent of the sample was using anti-
depressant medications at the time of baseline data collection, and 15% had 
previously been exposed to psychological interventions. 
Sixty percent of participants within the LI-CBT treatment condition associated
the onset of IBS with an episode of infectious gastroenteritis. The mean level 
of alcohol consumption was 4.3 units per week (S.D. = 7.9). The SH sample 
did not report weekly alcohol consumption. The sample consisted mainly of 
white-British participants (95%) with only one participant from a white-other 
ethnic origin. The sample had a household income, ranging from £<15’000 
to £99’999, with 30% of the sample having a household income of £20’000 - 
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£29’999. Eighty five percent of the sample did not report smoking on 
enrolment. 
Figure 1 shows the flow of participants through the study. One participant 
was lost at twelve weeks follow up within the LI-CBT, SH and TAU treatment 
conditions, reasons for which were not volunteered by participants. The 
remaining participants continued to complete the twenty-six week follow up. 
Of the thirteen potential participants selected for post intervention 
interviews, three declined participation: two of whom did not provide further 
information, one was unable to participate as study closure and data analysis
had already begun owing to time constraints. 
Gastrointestinal symptoms
Table 4 describes changes within the four treatment conditions in relation to 
overall symptom profiles as measured with GSRS-IBS. 
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Table 4: Participant GSRS-IBS overall scores
and change from baseline to 26 week follow up
   Table 4
Treatment condition
HI-CBT
(n = 5)
LI-CBT
(n = 5)
SH
(n = 5)
TAU
(n = 5)
    Baseline Mean 50.4 51.2 49.2 38.6
  S.D. 14.7 11.8 11.2 10.8
    12 weeks Mean 34.2 39.0 45.2 45.4
  S.D. 12.2 11.47 19.2 14.0
    26 weeks Mean 33.2 37.8 42.0 47.4
  S.D. 11.4 9.6 15.1 19.5
    Change 
    (baseline to 26 weeks)
Mean
  S.D.
-17.2
9.2
-13.4
11.5
-7.2
10.5
8.8
10.6
Participants within the HI-CBT and LI-CBT treatment conditions experienced a
mean overall reduction in total symptom scores by -17.2 (S.D. = 9.2) and 
-14.4 (S.D. = 11.5) respectively between baseline and 26 weeks. The SH 
treatment condition resulted in a mean reduction of symptom scores by -7.2 
points (S.D. = 10.5). Participants with the TAU condition experience a mean 
increase in symptom scores of 8.8 (S.D. = 10.6). 
22
Anxiety and depression
Tables 5 and 6 show that participants within the HI-CBT condition 
experienced improvements in both anxiety and depression. 
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Table 5: Degree of change in GAD-7 mean scores
     
Treatment condition
HI-CBT
(n = 5)
LI-CBT
(n = 5)
SH
(n = 5)
TAU
(n = 5)
           Baseline
                   S.D.
7.8 6.8 9.8 9.2
3.1 5.3 5.6 4.8
           26 weeks
                   S.D.
4.8 5.0 7.4 7.8
5.9 4.9 6.9 5.5
          Change
                  S.D.
-3.0 -1.8 -2.4 -1.4
3.4 3.5 3.9 1.9
Table 6: Degree of change in PHQ-9 mean scores
     
Treatment condition
HI-CBT
(n = 5)
LI-CBT
(n = 5)
SH
(n = 5)
TAU
(n = 5)
          Baseline
                   S.D.
10.2 8.4 11.2 13.0
5.5 6.6 6.3 6.6
          26 weeks
                   S.D.
6.8 6.8 9.2 11.6
7.4 7.5 6.9 5.8
          Change
                   S.D.
-3.4 -1.6 -2.0 -1.4
2.1 4.0 3.4 3.4
Participants within the HI-CBT condition experienced a mean change in 
depression of -3.4 points (S.D. = 2.1) compared to -1.6 (S.D. = 4.0) within LI-
CBT, -2.0 (S.D. = 3.4) within SH and -1.4 (S.D. = 3.4) within TAU. These data 
demonstrate that all participants experienced some reduction in GAD-7 and 
PHQ-9 scores at 26 weeks, with the greatest reductions noted within the HI-
CBT treatment condition. 
Quality of life
IBS-QOL scores improved by a mean of 23.1 (S.D. = 17.2) points for HI-CBT, 
24.1 (S.D. = 23.5) for LI-CBT and by 9.9 (S.D. = 19.1) for the SH condition at 
26 week follow up. Participants within the TAU condition experienced a 
deterioration in quality of life with a mean score reduction of -3.8 points (S.D.
= 9.1).
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Initial perceptions of treatment
SH participants were mostly disappointed with the treatment arm they had 
been allocated, some of whom clearly stated that they would have preferred 
a therapist-led course of treatment. These views were reinforced by some 
participants receiving HI-CBT who also felt that they would have been 
disappointed with the TAU or SH treatment conditions. There was also doubt 
regarding the likely benefits of treatment among the SH group prior to 
intervention delivery. Amongst the three intervention conditions, participants
described how their motivation to participate in CBT treatments was driven 
by the failure of conventional medical therapy or because CBT was perceived
as a ‘last resort’. There was also some evidence that contradictory advice 
received from medical professionals had some bearing on the initial 
perceptions of treatment. This was particularly evident when participants 
detected ambiguity amongst professionals regarding the cause of IBS.
25
Experience of therapeutic task execution
Participants described relaxation techniques as useful in the day-to-day 
management of their IBS. Some participants struggled with their ability to 
implement relaxation techniques which appeared to relate to the mode of 
treatment. Participants receiving SH found the interventions much more 
difficult to implement than those within delivered therapies. Therapist-
facilitated relaxation within HI-CBT (the therapist physically doing the 
relaxation activities alongside participants) was highly valued by 
participants. Furthermore, constructive feedback from therapists increased 
confidence in some participant’s ability to correctly execute relaxation 
techniques. 
The intensity of HI-CBT treatments and the depth and breadth of treatment 
could be problematic and preparation for therapy was recommended by 
participants. These issues were not a feature of the SH or LI-CBT approaches,
although some lower intensity treatment approaches were considered by 
participants as ‘too superficial’ or not of sufficient intensity for addressing 
complex problems. Many of the participants valued the prospect of face to 
face therapy which may in turn impact initial perceptions of treatment and 
participants’ ability to correctly execute tasks. Executing therapeutic tasks 
such as relaxation exercises was difficult for participants experiencing 
dyslexia, although such issues were overcome with therapist intervention or 
family support. 
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Practical considerations for engagement
Lack of therapist input was particularly problematic for SH participants and 
was considered essential by participants within the LI-CBT and HI-CBT forms 
of treatment. Participants specifically suggested that face to face contact 
with therapists was highly valuable.  Social support or interaction was useful 
for some participants when implementing treatment related activities, whilst 
others chose to remain autonomous and carry out their activities alone 
describing a reluctance to “burden” friends or family with IBS related issues. 
Where participants received treatment from a therapist, the personality of 
the therapist had the potential to influence the execution of therapeutic 
tasks for some participants, and a ‘good personality’ was seen as a facilitator
to building an effective therapeutic relationship. An additional benefit for 
participants receiving lower-intensity treatment was the self-help materials, 
which they considered were a valuable resource. There was some concern 
that the materials could be difficult to tailor to individual circumstances, 
although the presence of narratives or real-life scenarios within the material 
improved the applicability of the material as described by some participants. 
There was a strong emphasis on the need for therapist delivered treatment 
to be sufficiently flexible to fit around working patterns and other activities. 
These issues were particularly important for participants in employment. HI-
CBT participants suggested documentation within the HI-CBT intervention 
could have been improved. Participants suggested that the number of 
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sessions and session duration should be tailored to meet individual needs 
and remain flexible rather than rigidly applied in accordance to treatment 
protocols. 
Perceived utility of treatment
A number of participants felt that their knowledge relating to IBS improved 
over the course of the study. Generally, participants developed confidence in 
the notion that IBS may be related to stress or heightened states of arousal. 
Where participants perceived treatment to be useful, the interventions 
enabled some participants to accept and recognise the role of stress relating 
to IBS symptoms and reduce doubt they had about the accuracy of IBS 
diagnoses. Relaxation was eventually considered a particularly useful 
intervention component for some participants who originally reported 
difficulty executing relaxation tasks once their therapist had addressed these
difficulties. However, there were other participants who did not report 
experiencing symptom reduction from utilising relaxation techniques. Whilst 
some participants described symptom improvement, others described 
treatment benefits associated with improved coping mechanism and the 
wider application of interventions to other aspects of life.
Discussion
This study aimed to investigate the feasibility and acceptability of nurse-
delivered LI-CBT for IBS. A tailored nurse-delivered CBT treatment protocol 
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was developed and the number of participants needed to screen in relation 
to the numbers successfully randomised were examined. The qualitative 
data was collected to explore the experience of participants undergoing 
treatment conditions and to identify barriers and facilitators to the 
implementation of the trial interventions. 
The participants within this study were successfully recruited directly from 
secondary care gastrointestinal outpatient clinics within a large university 
teaching hospital. The conversion rate to response was approximately 34% 
when methods were used to invite participants to take part via postal return. 
A total of 104 participants were required to be approached to achieve 22 
screening visits and 20 randomisations. The conversion rate from 
participants approached to randomisation was 20.8%. Future recruitment 
programs utilising the same methods should therefore consider that around 
100 patients will need to be approached to achieve n = 20 within the clinical 
setting where the feasibility study took place. Explanations for participants 
not taking part were explored although it is not clear whether the clinical 
research element (i.e. completion of questionnaires) or the required 
commitment to therapy (12 hours if randomised to HI-CBT) deterred 
potential participants, or whether some other unforeseen phenomena was 
responsible.
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Contacting participants to identify issues relating to taking part was much 
more difficult than anticipated. For example, it was not possible to contact 
participants with whom the investigator had no direct contact, and it is likely 
that some intent-to-please bias may have influenced the responses obtained 
from participants by the investigator. It is for these reasons that few data 
were collected relating to reasons for not taking part. It is possible to infer 
that higher recruitment into this feasibility study may have changed the data
observed, although there is little in the way of guidance for researchers 
conducting feasibility studies regarding sample size.
Within the SH intervention, some of the participants who were interviewed in
the post-treatment phase reported disappointment regarding the lack of 
therapist interaction and felt that some therapeutic tasks contained within 
the SH materials were difficult to execute due to a lack of therapist guidance.
They also had preconceptions about the utility of treatment relating to doubt 
that the SH intervention would help their IBS. It is therefore not surprising to 
observe that both HI-CBT and LI-CBT interventions may have had a greater 
impact on QOL and symptom severity than SH. However, the SH modules 
utilized in the study were not originally developed to serve as a stand-alone 
intervention and were used alongside therapist feedback and interaction via 
the internet (Hunt et al., 2009).  The LI-CBT intervention is therefore more 
closely related to the original intervention developed by Hunt and colleagues
30
and in the original format appeared to have a positive effect on symptom 
severity and health-related QOL. 
Furthermore, since the original evaluation and development of this 
intervention, the format has now been expanded upon to form a stand-alone 
self-help treatment aimed at improving symptom Severity, HRQOL, and 
Depressive symptoms (Hunt et al., 2014). The SH book has also since been 
published (Hunt, 2016). In relation to the findings within the qualitative data 
here, some of the major additions and expansions to the SH book included 
clinical vignettes and examples intended to personalize the text and help 
patients apply it to their own lives. The Improving Access to Psychological 
Therapies (IAPT) service now lists the book among their recommended 
manuals for the management of IBS (IAPT, 2017).
Participants within the SH condition reported marginally greater 
improvements in depression (PHQ-9) and anxiety (GAD-7) scores than those 
receiving therapist delivered LI-CBT, which seems counterintuitive 
considering the SH participants’ disappointment regarding the lack of face-
to-face interaction. 
The findings which suggest participants valued face-to-face contact with a 
therapist are of interest, since these issues are currently debated within the 
literature. For example, the results of a recent study suggest that therapists 
31
rate face-to-face therapy as a more therapeutic experience than other types 
of treatment such as internet based therapy where such contact is absent 
(Bengtsson et al., 2015). Authors also suggest that psychological 
interventions delivered on the telephone present a variety of challenges, 
including a lack of control over environments, potential breaches of 
confidentiality and difficulty developing therapeutic alliance without face-to-
face support (Brenes et al., 2011). Researchers have also found that 
therapists achieved successful working alliances faster and more readily 
during face-to-face therapy (Bengtsson et al., 2015). Nonetheless, 
interventions underpinned by technology such as internet and telephone 
may increase access to evidence based interventions (Mohr et al., 2012). 
Despite this, internet therapy has been described as impersonal, non-
genuine and inhibitory (Bendelin et al., 2011).
Some participants described the benefits of relaxation techniques which, 
when implemented successfully, helped participants to manage symptoms 
during daily life events and activities. Relaxation was evaluated particularly 
positively when facilitated by the therapist. The aim of including relaxation 
techniques within the multi-component interventions trialled within this 
study was to reduce sympathetic nervous system arousal which may be 
responsible for the exacerbation of IBS symptoms and maintenance of 
underlying psychopathology such as anxiety and higher states of arousal. In 
this context, relaxation utilised in conjunction with other psychological 
32
therapy components was predicted to reduce levels of psychological distress 
by promoting a physiological state in opposition to how the body reacts 
under stressful situations (Brent et al., 2009). These observations are also in 
keeping with the biopsychosocial models of IBS. Perhaps the most relevant 
findings in relation to the qualitative data were those themes which elucidate
the potential barriers and facilitators to the implementation of the trialled 
interventions. 
The aim of this research was to explore factors relating to the feasibility of 
nurse delivered, LI-CBT interventions for the treatment of IBS. The 
quantitative data collected during this study suggests that LI-CBT may 
benefit patients with IBS in terms of the outcome measures captured during 
the feasibility study. However, the data gathered also potentially indicates 
that the changes brought about by the three interventions may relate to 
treatment intensity and dose, although there is insufficient data from this 
study on which to firmly base these assumptions. 
Overall, the qualitative data suggests that LI-CBT was accepted by 
participants as a useful form of treatment for IBS within secondary care 
gastrointestinal clinics. This is perhaps further supported by the QOL 
deterioration of participants within the TAU condition of the study. The 
qualitative data has helped to provide a novel and valuable insight into the 
use of these various CBT interventions within gastrointestinal nursing 
33
practice. The findings of the qualitative data may therefore improve the 
acceptability and suitability of the LI-CBT intervention if the identified 
facilitators and barriers to treatment are considered during future 
intervention development and testing.
Despite the inability of the study to draw conclusions about the efficacy of 
the trialled interventions, the study does have some implications for 
gastrointestinal nursing practice. Nurses working within gastroenterology 
should consider the access that patients have to psychological interventions 
within their specialities, particularly considering the recommendations 
afforded by NICE for patients with chronic, treatment-refractory symptoms. 
Most importantly, this paper further highlights the importance of 
psychosocial aspects of presentations which should be carefully considered 
during nursing assessment and the evaluation of care for patients, 
particularly those with functional gastrointestinal problems such as IBS.
Strengths and limitations
This study provides an insight into the use of LI-CBT interventions when 
implemented during a feasibility study within gastrointestinal clinics. The 
recruitment difficulties identified during the conduct of this feasibility study 
highlight some of the challenges faced by researchers when conducting 
complex studies within clinical settings. Nonetheless, for future research 
studies to be successful, these recruitment issues need to be further 
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explored and addressed. Despite attempts to gather reasons for non-
participation, it is still possible that the lack of recruitment to the study may 
be indicative of a lack of acceptability of the modes of treatment.
The shortfall of participants recruited into this study may have implications 
for the data collected, namely the small sample size. A novel, nurse-
delivered intervention has been trialled within gastrointestinal clinical 
practice which has been developed in close collaboration with service users. 
The qualitative data collected suggests further improvements to the LI-CBT 
intervention may be required to enhance the quality of nurse-delivered LI-
CBT. The methods utilised within this feasibility are robust and have been 
scrutinised through extensive peer review. In particular, the mixed-method 
study design has generated data which makes a novel contribution to our 
understanding of how CBT interventions may be perceived by trial 
participants. Such methods are likely to be worthwhile within future research 
studies.
Conclusion
The data generated during this study would suggest that nurse delivered, LI-
CBT may be a feasible mechanism for CBT intervention delivery within 
secondary care outpatient gastroenterology. Significant difficulties in 
recruitment were experienced throughout the duration of this study which 
may render further investigations unfeasible if problems with recruitment are
not addressed. Themes generated from the qualitative data have highlighted
a variety of barriers and facilitators to the implementation of CBT treatment 
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approaches as implemented during the conduct of a clinical trial. Participants
struggled with the autonomy required to complete SH interventions, with 
most participants valuing face-to-face interaction with a therapist. 
Facilitators to the implementation of the interventions included the 
successful implementation of relaxation techniques and the explicit use of 
narratives within SH materials to enable participants to self-identify with the 
text. Participants also felt that preparation may improve engagement with 
therapy and improve the acceptability of CBT interventions for IBS. 
This study was situated within the feasibility and pilot remit of the Medical 
Research Council’s guidelines for the evaluation of complex interventions 
(MRC, 2008). Although this study adds knowledge in relation to the potential 
barriers and facilitators to the successful implementation of the trialled 
interventions, the significant difficulties in recruiting participants to the 
feasibility trial suggest that further feasibility and piloting work is required to 
overcome these barriers if a large scale RCT is to be feasible at a single 
study centre. Further development of these lower-intensity interventions in 
collaboration with service users is required and may improve the 
acceptability and relevance of the interventions within future studies.
Ethics and dissemination: A favourable opinion for this research was 
granted by the Nottingham 2 Research Ethics Committee. 
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